Use of SGLT2i and ARNi in patients with atrial fibrillation and heart failure in 2021-2022: an analysis of real-world data.

Alvaro AlonsoAlanna A MorrisAshley I NaimiAniqa B AlamLinzi LiVinita SubramanyaLin Yee ChenPamela L Lutsey

Published in: medRxiv : the preprint server for health sciences (2023)

Use of ARNi and SGLT2i in patients with AF and HF is suboptimal, particularly among females and older individuals, though utilization is increasing. These results underscore the need for understanding reasons for these disparities and developing interventions to improve adoption of evidence-based therapies among patients with comorbid AF and HF.

Keyphrases

atrial fibrillation
acute heart failure
heart failure
electronic health record
physical activity
middle aged
community dwelling
big data
left ventricular
healthcare
data analysis